119 related articles for article (PubMed ID: 38192114)
1. Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas.
Somay E; Yilmaz B; Topkan E; Ozdemir BS; Ozturk D; Besen AA; Mertsoylu H; Selek U
Int J Biol Markers; 2024 Mar; 39(1):80-88. PubMed ID: 38192114
[TBL] [Abstract][Full Text] [Related]
2. The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients.
Somay E; Topkan E; Pehlivan UA; Yilmaz B; Besen AA; Mertsoylu H; Pehlivan B; Selek U
Tomography; 2024 Jan; 10(1):79-89. PubMed ID: 38250953
[TBL] [Abstract][Full Text] [Related]
3. Low hemoglobin levels predict increased radiation-induced trismus rates in nasopharyngeal cancer.
Somay E; Yilmaz B; Topkan E; Pehlivan B; Selek U
Oral Dis; 2024 Apr; 30(3):1052-1060. PubMed ID: 37154238
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin-to-platelet ratio in predicting the incidence of trismus after concurrent chemoradiotherapy.
Somay E; Yilmaz B; Topkan E; Kucuk A; Haksoyler V; Pehlivan B; Selek U; Araz K
Oral Dis; 2023 Oct; 29(7):2962-2970. PubMed ID: 36038508
[TBL] [Abstract][Full Text] [Related]
5. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
Topkan E; Somay E; Yilmaz B; Pehlivan B; Selek U
BMC Cancer; 2023 Jul; 23(1):651. PubMed ID: 37438683
[TBL] [Abstract][Full Text] [Related]
6. Global Immune-Nutrition-Inflammation Index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients.
Somay E; Topkan E; Bascil S; Kılıc Durankuş N; Senyürek Ş; Ozturk D; Pehlivan B; Selek U
Biomol Biomed; 2024 Jun; ():. PubMed ID: 38860864
[TBL] [Abstract][Full Text] [Related]
7. The predictive usefulness of the novel "combined hemoglobin-to-platelet ratio and maximum mouth opening index" on prevalence of radiation induced trismus in patients with nasopharyngeal cancer.
Somay E; Yilmaz B; Topkan E; Kucuk A; Pehlivan B; Selek U
Head Neck; 2023 Jul; 45(7):1823-1831. PubMed ID: 37173823
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy.
Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
BMC Oral Health; 2023 Apr; 23(1):231. PubMed ID: 37081475
[TBL] [Abstract][Full Text] [Related]
9. Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas.
Yilmaz B; Somay E; Topkan E; Pehlivan B; Besen AA; Mertsoylu H; Selek U
J Stomatol Oral Maxillofac Surg; 2024 Jan; 125(6):101786. PubMed ID: 38286220
[TBL] [Abstract][Full Text] [Related]
10. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers.
Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
Strahlenther Onkol; 2023 Oct; 199(10):910-921. PubMed ID: 37566126
[TBL] [Abstract][Full Text] [Related]
11. A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer.
Kucuk A; Topkan E; Ozkan EE; Ozturk D; Pehlivan B; Selek U
Int J Immunopathol Pharmacol; 2023; 37():3946320231187759. PubMed ID: 37404137
[No Abstract] [Full Text] [Related]
12. Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas.
Topkan E; Selek U; Kucuk A; Pehlivan B
J Inflamm Res; 2022; 15():5413-5423. PubMed ID: 36158517
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.
Yilmaz B; Somay E; Selek U; Topkan E
Ther Clin Risk Manag; 2021; 17():1113-1121. PubMed ID: 34703240
[TBL] [Abstract][Full Text] [Related]
14. Initial neutrophil-to-lymphocyte ratio predicts radiation-induced trismus in parotid gland cancer.
Somay E; Yilmaz B; Topkan E; Kucuk A; Pehlivan B; Selek U
Oral Dis; 2023 Oct; 29(7):2772-2779. PubMed ID: 36349491
[TBL] [Abstract][Full Text] [Related]
15. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer.
Topkan E; Kucuk A; Ozkan EE; Ozturk D; Besen AA; Mertsoylu H; Pehlivan B; Selek U
Discov Oncol; 2023 Dec; 14(1):230. PubMed ID: 38091179
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pan-immune-inflammation value (PIV) in nasopharyngeal carcinoma patients.
Zhang N; Hou T; Zhang S; Ling J; Jiang S; Xie Y; Liu X; Hu C; Feng Y
Heliyon; 2024 Jan; 10(2):e24804. PubMed ID: 38312571
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
Wu L; Chung YL
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):165-176. PubMed ID: 30654091
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis.
Liu H; Chen QY; Guo L; Tang LQ; Mo HY; Zhong ZL; Huang PY; Luo DH; Sun R; Guo X; Cao KJ; Hong MH; Mai HQ
Radiat Oncol; 2013 Mar; 8():70. PubMed ID: 23521779
[TBL] [Abstract][Full Text] [Related]
19. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
[TBL] [Abstract][Full Text] [Related]
20. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.
Guven DC; Erul E; Yilmaz F; Yasar S; Yildirim HC; Ercan F; Kaygusuz Y; Cayiroz K; Ucdal MT; Yesil F; Yazici G; Cengiz M; Gullu I; Aksoy S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2471-2478. PubMed ID: 36565325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
